Feb. 27 court date for Charter test of stem cell program; Foes say enterprise is illegal because it's outside state control
By San Francisco Chronicle,
San Francisco Chronicle
| 12. 07. 2005
Alameda County Superior Court Judge Bonnie Sabraw set a trial for Feb. 27 to decide whether California's Proposition 71 stem cell program violates the state Constitution.
Sabraw presided over a 30-minute hearing in her Hayward courtroom Tuesday to work out a timetable for the next critical phase in litigation brought by plaintiffs who say the voter-approved stem cell enterprise is illegal because it operates outside "the exclusive management and control of the state."
While the court proceeding was under way, stem cell policymakers were in Southern California to lay groundwork for their long-awaited first round of financing. Their goal is to generate up to $50 million, more than enough to cover initial training grants for would-be stem cell scientists at California medical schools and other nonprofit research institutions.
Officials meeting at City of Hope Cancer Research Center outside Los Angeles adopted guidelines governing profit rights and other "intellectual property" rules for researchers receiving Prop. 71 grants. A much more detailed review of final policies is just beginning.
Critics argue that stem cell policy makers are allowing researchers too much control...
Related Articles
By Carl Zimmer and Marco Hernandez , The New York Times | 07.01.2026
Scientists have long dreamed of discovering the alchemy by which chemicals can be turned into life. On Wednesday, a team at the University of Minnesota announced that it had taken a major step toward that vision.
Blending together dozens of...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Ed Pilkington, The Guardian | 06.12.2026
Desperate US parents paying up to $20,000 a session for a procedure scientists say could be bogus
Autistic children as young as 18 months old are being injected with human stem cells derived from umbilical cords in unapproved, unproven and...
By Tobi Thomas, The Guardian | 06.10.2026
The UK’s stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found.
A hematopoietic stem cell transplant, often...